• Russia Launches Comprehensive Study Genomes Of Living Organisms In Arctic Region

    Bio-IT World | A project to study the genomes of living organisms in the Arctic region, known as “A Thousand Arctic Genomes,” has been launched in Russia. As part of the project, scientists will create genetic data banks and perform whole-genome sequencing of Arctic inhabitants in order to assess biodiversity and use the data obtained to preserve it.

    Dec 10, 2024
  • ‘Therapeutic EVs’ in a Nasal Spray Could One Day Treat Alzheimer’s Disease

    Bio-IT World | It sounds too good to be true: a nasal spray that delays Alzheimer’s-related behavioral and cognitive problems a decade or more after initial diagnosis. But promising first steps in that direction have already been taken using “therapeutic EVs” (extracellular vesicles) restricting the activation of inflammatory cytokines in the brain of mice.

    Dec 5, 2024
  • Building Tiny Biocompatible Batteries with Heart-Defibrillating Power

    Bio-IT World | In a paper published last week in Science, researchers from the University of Oxford, UK, demonstrate how microprocessors can be created from soft, biocompatible, nanoliter-scale hydrogel droplets. This work builds on a study published last month in Nature Chemical Engineering introducing poppyseed-sized droplet batteries that can be used to power such systems for various bionic and biomedical applications.

    Dec 4, 2024
  • Barcelona Research Institutions Launch Joint Program on Evolutionary Medical Genomics

    Bio-IT World | Three research institutions in Barcelona have teamed up to launch the world’s first Joint Program on Evolutionary Medical Genomics. The initiative, launched last month at an inaugural symposium in Barcelona Biomedical Research Park (PRBB), is a collaboration between the Centre for Genomic Regulation (CRG), the Department of Medicine and Life Sciences at the Universitat Pompeu Fabra (UPF), and the Institut de Biologia Evolutiva

    Dec 3, 2024
  • Follow the Money: Seaport Therapeutics Glyph Platform, Pathos AI Expansion, More

    Bio-IT World | Seaport nets funds for its Glyph technology platform; Pathos AI plans to accelerate its AI-powered drug development platform; Alentis Therapeutics pursues antibody drug conjugates; and more.

    Nov 26, 2024